Icu Medical Inc's Revenue in the fiscal year 2025 $ 2,231.26 millions
Icu Medical Inc's Revenue in the fiscal year 2024 $ 2,382.05 millions
Icu Medical Inc's Revenue in the fiscal year 2023 $ 2,259.13 millions
Icu Medical Inc's Revenue in the fiscal year 2022 $ 2,280.00 millions
Icu Medical Inc's Revenue in the fiscal year 2021 $ 1,316.31 millions
ICUI Revenue second quarter 2026 Y/Y Growth Comment
Icu Medical Inc reported Revenue growth of 0.66% year on year in the second quarter 2026, to $ 551.68 millions, this is lower than Icu Medical Inc's recent average Revenue improvement of 21.87%.
Looking into second quarter 2026 results within Medical Equipment & Supplies industry 130 other companies have achieved higher Revenue growth. While Icu Medical Inc' s Revenue increase of 0.66% ranks overall at the positon no. 2717 in the second quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Icu Medical Inc's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
158.9 %
4.71 %
-10.13 %
(Mar 31 2017)
ICUI's II. Quarter Q/Q Revenue Comment
Icu Medical Inc achieved in the II. Quarter 2026 below company average Revenue growth of 4.24% quarter on quarter, to $ 551.68 millions.
Although the II. Quarter 2026 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the II. Quarter surge, eclipses the -9.28% growth in the II. Quarter a year ago
Within Medical Equipment & Supplies industry 49 other companies have achieved higher Revenue quarter on quarter growth. While Icu Medical Inc's Revenue growth quarter on quarter, overall rank is 1207.
Icu Medical Inc achieved in the II. Quarter 2026 below company average Revenue growth of 4.24% quarter on quarter, to $ 551.68 millions.
II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -9.28% in the II. Quarter a year ago.
Within Medical Equipment & Supplies industry 49 other companies have achieved higher Revenue quarter on quarter growth. While Icu Medical Inc's Revenue growth quarter on quarter, overall rank is 1207.
Icu Medical Inc's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 2,160.00
$ 2,156.38
$ 2,231.26
$ 2,319.58
$ 2,371.55
Y / Y Revenue Growth (TTM)
-8.92 %
-10.89 %
-6.33 %
-0.9 %
2.9 %
Year on Year Revenue Growth Overall
Ranking
# 1785
# 1464
# 534
# 1762
# 1471
Seqeuential Revenue Change (TTM)
0.17 %
-3.36 %
-3.81 %
-2.19 %
-2 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2781
# 2014
# 678
# 2036
# 1337
Cumulative Revenue growth Comment
Icu Medical Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Icu Medical Inc's annual Revenue decline would be -8.92% year on year to $2,160 millions.
In the Healthcare sector 283 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1464 to 1785.
Icu Medical Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Icu Medical Inc's annual Revenue decrease would be -8.92% year on year to $2,160 millions.
In the Healthcare sector 283 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1464 to 1785.
About Icu Medical Inc Revenue Growth Rates (ICUI), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
1.06%